Pamela Kunz | |
---|---|
Born | Massachusetts, USA |
Spouse | Jeffrey Kwan |
Relatives | Thomas Kunz (father) |
Academic background | |
Education | BA, 1994, Dartmouth College MD, 2001, Geisel School of Medicine |
Academic work | |
Institutions | Yale Cancer Center Stanford University School of Medicine |
Pamela Lyn Kunz is an American oncologist. She is the leader of the Gastrointestinal Cancers Program at Yale Cancer Center and Smilow Cancer Hospital and director of GI Medical Oncology within the Section of Medical Oncology. She was formerly the director of the Stanford Neuroendocrine Tumor Program before leaving,in part due to harassment. Kunz was also recognized as one of the 100 Influential Women in Oncology by OncoDaily. [1]
Kunz was born to parents Thomas and Margaret Kunz and grew up with her brother David. Her father was a biologist specializing in the study of bats at Boston University. [2] She attended Dartmouth College for her Bachelor of Arts degree in 1994 and Geisel School of Medicine for her medical degree in 2001. [3] In 2000,she was the co-recipient of the "Best Oral Presentation by a Resident or Medical Student" Award and elected student body president. [4]
Kunz joined Stanford University School of Medicine in 2001 as a resident in Internal Medicine,during which she said she felt "supported,mentored and valued." [5] She remained at the institution for a fellowship in Oncology and joined the Division of Oncology faculty in 2010. [6] During her tenure at Stanford,Kunz's research focused on treating patients with gastrointestinal malignancies and neuroendocrine tumors,leading to the design,development and execution of clinical trials in this field. [3] As an assistant professor of medicine,Kunz was appointed the medical director of the Stanford's Neuroendocrine Tumor Program,a program aimed at providing clinical care to patients with neuroendocrine tumors. [7] She also serves on the executive committee of the North American Neuroendocrine Tumor Society (NANETS) and chairs their finance committee and the Membership &Diversity Committee. [6] During the 2019–20 academic year,Kunz was appointed a faculty research fellow at Stanford's Michelle R. Clayman Institute for Gender Research. [8] Through this fellowship,she examined gender representation in her field including the disparities of women in clinical trials and leadership roles. [5]
In early 2020,Kunz announced that she was leaving Stanford to accept a position as leader of the Gastrointestinal Cancers Program at Smilow Cancer Hospital at Yale Cancer Center and director of GI Medical Oncology within the Section of Medical Oncology. [9] She told The Stanford Daily that she was leaving Stanford as a result of "microaggressions...that had caused significant barriers to her success." [10] In July 2020,Kunz was appointed the leader of gastrointestinal cancers program at Yale Cancer Center and Smilow Cancer Hospital and an associate professor of medicine in the Division of Oncology. [11]
Kunz is married and has three sons. She identifies as a feminist. [12]
Surgical oncology is the branch of surgery applied to oncology;it focuses on the surgical management of tumors,especially cancerous tumors.
Appendix cancer are very rare cancers of the vermiform appendix.
Greenwich Hospital is a teaching hospital in Greenwich,Connecticut,serving people in lower Fairfield County and lower Westchester County,New York.
Yale Cancer Center (YCC) was founded in 1974 as a result of an act of Congress in 1971,which declared the nation's "war on cancer". It is one of a network of 56 Comprehensive Cancer Centers designated by the National Cancer Institute (NCI). Currently directed by Dr. Eric Winer,the Cancer Center brings together the resources of the Yale School of Medicine (YSM),Yale New Haven Hospital (YNHH),and the Yale School of Public Health (YSPH).
Olufunmilayo I. Olopade born in the year 1957,is a Nigerian hematology oncologist,Associate Dean for Global Health and Walter L. Palmer,Distinguished Service Professor in Medicine and Human Genetics at the University of Chicago. She also serves as director of the University of Chicago Hospital's Cancer Risk Clinic.
Endocrine oncology refers to a medical speciality dealing with hormone producing tumors,i.e. a combination of endocrinology and oncology.
Prof. Suayib Yalcin MD is an eminent medical oncologist with special interest in cancer treatment and research. He has authored/co-authored more than 80 articles cited in science citation index. His main areas of research interest are gastrointestinal cancers also including neuroendocrine tumors and gastrointestinal stromal tumors as well as supportive care. After graduating from Hacettepe University in Ankara,Turkey in 1989,he became a Medical Oncologist in 1997,and worked as a post doctoral fellow at the Gastrointestinal Oncology Department at the MD Anderson Cancer Center in Houston,Texas. He was appointed as a full professor in 2004,while serving as a faculty at Hacettepe University Cancer Institute,he is also currently the former president of Turkish Society of Medical Oncology and also President of Turkish Association for Cancer Research and Control. He is an active member of ASCO,ESMO,IASGO,MMOF and immediate past national representative of Turkey in ESMO. He has participated in many clinical cancer research projects as a steering committee member,or principal investigator and serves as editorial board of several cancer journals. He currently works at Hacettepe University,Department of Medical Oncology where he continues to contribute to his field.
}}
Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.
Julie Ann Sosa is a professor and chair of the Department of Surgery at the University of California,San Francisco (UCSF) and holds the Leon Goldman,MD,Distinguished Professorship in Surgery. She currently serves as the Treasurer of the American Thyroid Association and Editor-in-Chief of the World Journal of Surgery.
Matthew Kulke is an American cancer researcher. He is the Chief of Hematology/Oncology,co-director of the BU/BMC Cancer Center and "Zoltan Kohn Professor" at the Boston University School of Medicine. His work has shed light on the molecular characteristics of neuroendocrine tumors and has led to the development of multiple new treatments for this condition. His research studies led to the development and approval of telotristat ethyl,a tryptophan hydroxylase inhibitor,for the treatment of patients with carcinoid syndrome. He has also contributed to early and late stage clinical trials of temozolomide,sunitinib,everolimus,and peptide receptor radiotherapy for neuroendocrine tumors.
Robert Maki is an American medical oncologist,Professor of Medicine at the Hospital of the University of Pennsylvania,He is a specialist in the management of and translational research regarding sarcoma,the group of connective tissue malignancies that include leiomyosarcoma,gastrointestinal stromal tumor (GIST),liposarcoma,angiosarcoma,Ewing sarcoma,desmoid tumor and many others.
Edith Peterson Mitchell is a retired Brigadier general of the United States Air Force and an oncologist. She is clinical professor of medicine and medical oncology at Thomas Jefferson University. In 2015,she became the president of the National Medical Association.
Andrea B. Apolo is an American medical oncologist specialized in bladder cancer research. She is an investigator in the National Cancer Institute's genitourinary malignancies branch and head of the bladder cancer section.
Maryam Beheshti Lustberg is an American breast oncologist. She is the Director of The Breast Center at Smilow Cancer Hospital and Chief of Breast Medical Oncology at Yale Cancer Center. Lustberg previously served as the Medical Director of Supportive Care at Ohio State's Comprehensive Cancer Center and President-Elect of the Multinational Association of Supportive Care in Cancer. She is also an associate editor for the peer-reviewed medical journal covering oncology nursing with respect to cancer survivors called Journal of Cancer Survivorship. Lustberg was also recognized as one of the 100 Influential Women in Oncology by OncoDaily.
Larissa Nekhlyudov is an American general internist. She is a professor of medicine at Harvard Medical School,primary care physician at the Brigham and Women’s Hospital and Clinical Director of Internal Medicine for Cancer Survivors at the Dana–Farber Cancer Institute.
Bhuvaneswari Ramaswamy is an American breast medical oncologist and hematologist. She serves as section chief of Breast Medical Oncology and as director of the Medical Oncology Fellowship Program in Breast Cancer for The Ohio State College of Medicine.
Allison Walsh Kurian is an American medical oncologist. She is a Professor of Medicine and Epidemiology &Population Health at Stanford University and an oncologist at the Stanford Cancer Institute.
Reshma Jagsi is an American Radiation oncologist. She is the Lawrence W. Davis Professor and Chair in the Department of Radiation Oncology and Senior Faculty Fellow in the Center for Ethics at Emory University. Overall,she is the author of over 450 published articles in peer-reviewed medical journals and continues scholarly research in three primary areas of interest:breast cancer,bioethics,and gender equity,with the support of grants from the National Institutes of Health (NIH),the Doris Duke Charitable Foundation,and the Susan G. Komen Foundation,for which she serves as a Senior Scholar.
Soma Sengupta,MD,PhD,MBA,FRCP,FANA,FAAN is a British-American physician-scientist. She is a specialty board certified neuro-oncologist board certified Neurologist,fellowship-trained in Integrative Medicine,and recipient of an MBA. Her clinical interests span treatment of brain tumor patients,integrative approaches in neurology and oncology,as well as healthcare policy. She is a full-time faculty member of the Department of Neurology at the University of North Carolina at Chapel Hill,where she is a Full Professor,Vice Chair,and Chief of the Division of Neuro-Oncology. She is also a Bye Fellow at Lucy Cavendish College,University of Cambridge,U.K.